- Entry
- $2.25
- Now
- $1.93 -14.2%
- Target
- —
- Score
- —
Potentially interesting setup developing in $PEPG ahead of conference week. Tiny market cap FDA Fast Track + Orphan Drug designation Late-breaking oral presentation Thursday by CEO Presentation wording specifically mentions “strong splicing correction” and “acceptable safety profile” Stock got destroyed after FDA hold concerns earlier this year but has been basing around long term support in the 1.40s and keeps reclaiming 1.50. Interesting part is nobody seems to be talking about it yet. Stocktwits dead quiet, Reddit barely mentioning it, …
— ORIGINAL POST ·
Why is nobody talking about $PEPG right now?
· r/pennystocks
· May 25, 2026